Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
89.12 CHF | +0.20% | +4.85% | +5.01% |
Apr. 24 | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
Apr. 24 | Novartis Says New Malaria Drug Formulation Safe and Effective for Babies | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.01% | 199B | |
+25.61% | 672B | |
+25.87% | 570B | |
-5.24% | 360B | |
+16.49% | 321B | |
+8.28% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
-8.75% | 149B | |
-5.21% | 147B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis Strikes $245 Million Settlement Over Exforge Drug Generics Litigation